First Wave BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FWBI and buy or sell other stocks, ETFs, and their options commission-free!About FWBI
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
CEOJason D. Sawyer
CEOJason D. Sawyer
Employees2
Employees2
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2014
Founded2014
Employees2
Employees2
FWBI Key Statistics
Market cap3.43M
Market cap3.43M
Price-Earnings ratio-0.44
Price-Earnings ratio-0.44
Dividend yield—
Dividend yield—
Average volume204.95K
Average volume204.95K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.84
52 Week high$5.84
52 Week low$0.9693
52 Week low$0.9693
Stock Snapshot
The current First Wave BioPharma(FWBI) stock price is $2.16, with a market capitalization of 3.43M. The stock trades at a price-to-earnings (P/E) ratio of -0.44.
During the trading day, First Wave BioPharma(FWBI) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for First Wave BioPharma(FWBI) stock has reached 0, versus its average volume of 204.95K.
The stock's 52-week range extends from a low of $0.97 to a high of $5.84.
The stock's 52-week range extends from a low of $0.97 to a high of $5.84.
People also own
Based on the portfolios of people who own FWBI. This list is generated using Robinhood data, and it’s not a recommendation.